Tissue matching and rejection

Every person's cells have unique antigens on their surface. The immune system recognises cells with different antigens as foreign and attacks them. If a transplanted kidney has very different antigens from the recipient, the immune system will mount a response: lymphocytes produce antibodies that attack the donor kidney. This is rejection.

To reduce rejection risk, the donor kidney is tissue-matched: a donor is chosen whose cell-surface antigens are as similar as possible to the recipient's. Close relatives are often the best match. Even with good matching, some difference remains, so additional measures are needed.

Immunosuppressant drugs

After transplantation, the recipient must take immunosuppressant drugs for the rest of their life. These drugs reduce the activity of the immune system, preventing it from rejecting the donor kidney. However, a suppressed immune system is less effective at fighting infections, so transplant patients are more vulnerable to infectious diseases.

This trade-off: protection of the transplanted organ versus increased infection risk: is a significant consideration. Patients must be carefully monitored and may need to avoid contact with people who have transmissible diseases.

Advantages and disadvantages compared to dialysis

FactorTransplantDialysis
FreedomNormal lifestyle possibleRegular hospital visits; restricted diet
DurationCan last many years (often 15–20+)Indefinite, as long as needed
RisksSurgery risk; rejection; infection from immunosuppressionInfection at access point; cardiovascular strain
AvailabilityLimited by donor organ shortageAlways available
CostHigh initial cost; lower long-termLower initial cost; high ongoing cost